265 related articles for article (PubMed ID: 19025433)
1. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
Van Tassell BW; Radwanski P; Movsesian M; Munger MA
Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
[TBL] [Abstract][Full Text] [Related]
2. [Combination therapy with PDE III inhibitor for heart failure].
Watanabe H; Kajimoto K; Kawana M
Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
[No Abstract] [Full Text] [Related]
3. Using Cardicor as first-line therapy in heart failure : CiBis iii.
Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
[No Abstract] [Full Text] [Related]
4. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase inhibition in heart failure.
Movsesian MA; Kukreja RC
Handb Exp Pharmacol; 2011; (204):237-49. PubMed ID: 21695643
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibitors. Its role in heart failure therapy.
Kohn IJ; Ribeiro LG
Arq Bras Cardiol; 1990 Jun; 54(6):361-5. PubMed ID: 1963059
[No Abstract] [Full Text] [Related]
7. Positive inotropic/vasodilator agents.
Colucci WS
Cardiol Clin; 1989 Feb; 7(1):131-44. PubMed ID: 2565161
[TBL] [Abstract][Full Text] [Related]
8. An overview of inotropic agents.
Vroom MB
Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):246-52. PubMed ID: 16959760
[TBL] [Abstract][Full Text] [Related]
9. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
[No Abstract] [Full Text] [Related]
10. Clinical use of beta-blocker therapy in patients with heart failure: a practical guide.
Doughty RN; Richards AM
N Z Med J; 2001 Feb; 114(1125):36-8. PubMed ID: 11277474
[No Abstract] [Full Text] [Related]
11. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors.
Lubbe WF; Podzuweit T; Opie LH
J Am Coll Cardiol; 1992 Jun; 19(7):1622-33. PubMed ID: 1350597
[TBL] [Abstract][Full Text] [Related]
12. Inotropic therapy of heart failure. Editorial comments on: Vasodilation and mechanoenergetic inefficiency dominates the effect of the "Ca2+ sensitizer" MCI-154 in intact pigs.
Duncker DJ; Verdouw PD
Scand Cardiovasc J; 2002 May; 36(3):131-5. PubMed ID: 12079634
[No Abstract] [Full Text] [Related]
13. [Drugs used in cardiovascular diseases and cytokines].
Andrzejczak D; Górska D
Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 5 inhibitors: are they cardioprotective?
Reffelmann T; Kloner RA
Cardiovasc Res; 2009 Jul; 83(2):204-12. PubMed ID: 19474180
[TBL] [Abstract][Full Text] [Related]
15. [beta-Receptor blockers: a new principle in the therapy of heart failure?].
Schotten U; Hanrath P
Dtsch Med Wochenschr; 1997 Mar; 122(13):387-90. PubMed ID: 9138910
[No Abstract] [Full Text] [Related]
16. [Chronic heart failure and sudden death: the message of CIBIS-III].
Dequarti MC; Poggio L; Vanoli E
Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure.
Guazzi M
Circ Heart Fail; 2008 Nov; 1(4):272-80. PubMed ID: 19808302
[No Abstract] [Full Text] [Related]
18. Recent developments in the treatment of congestive heart failure.
Hood WB
Trans Am Clin Climatol Assoc; 1991; 102():123-8; discussion 128-30. PubMed ID: 1983372
[No Abstract] [Full Text] [Related]
19. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology.
Bristow MR
Circ Res; 2011 Oct; 109(10):1176-94. PubMed ID: 22034480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
